Updated on 18 December 2012
What is the source of funding for ITRI biomed labs?
Typically, 60 percent of the funding for the bio labs at ITRI comes from government projects. Another 30 to 35 percent revenue for the bio labs is generated from the industrial services that we provide. And around five percent of the revenue comes from the IP or the spin-off companies.
For the new pharmaceutical companies, ITRI offers its GMP manufacturing procedure and does the proof-of-concept. We also offer the testing equipment to do clinical trials.In medical devices, we do offer the product IP and help in finding the key components from the Taiwanese industry. So, product IP is not our only role, we have to have the linkage to all the suppliers to come up with low cost products or solutions. We link the local industry to suppliers.
Also, we come up with some amount of devices for the clinical trials. We don't do mass production.